SHENGDA BIO-PHARM's private placement stock application has been approved for registration by the China Securities Regulatory Commission
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, SHENGDA BIO-PHARM announced that the company recently received the "Approval on Zhejiang Shengda Bio-Pharmaceutical Co., Ltd.'s Application for Stock Issuance Registration to Specific Objects" issued by the China Securities Regulatory Commission, agreeing to the company's application for stock issuance registration to specific objects
According to the Zhitong Finance APP, SHENGDA BIO-PHARM (603079.SH) announced that the company recently received the "Approval on Zhejiang Shengda Biopharmaceutical Co., Ltd.'s Application for Stock Issuance Registration to Specific Objects" issued by the China Securities Regulatory Commission, agreeing to the company's application for stock issuance registration to specific objects